跳至主要内容
临床试验/NCT04995822
NCT04995822进行中(未招募)不适用

Post Market Clinical Follow-up of EUROSTEM Femoral Stem

EUROS9 个研究点 分布在 1 个国家目标入组 131 人开始时间: 2021年5月21日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
131
试验地点
9
主要终点
Safety of EUROSTEM Femoral Stem

研究概览

简要总结

EUROSSTEM is intended for use in primary and revision total hip replacement surgery.

Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components.

As part of post market vigilance, EUROS will collect data on EUROSTEM performances and safety

详细描述

Post market observational study. This study is multicenter, prospective, non comparative.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient who received EUROSTEM
  • Patient informed of its participation to the study
  • Patient aged over 18 to date of surgery

排除标准

  • Patient presenting a contraindication to EUROSTEM implantation.
  • Patient who refused to participate to the study
  • Vulnerable subjects

结局指标

主要结局

Safety of EUROSTEM Femoral Stem

时间窗: 1 year

Collect the safety of the device trought complications occurence rate

次要结局

  • Survival of EUROSTEM Femoral Stem(10 year)
  • Radiological performances of EUROSTEM Femoral Stem(1 year)
  • Clinical performances of EUROSTEM Femoral Stem(1 year)

研究者

发起方
EUROS
申办方类型
Industry
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验